AstraZeneca PLC (AZN)

NYSE: AZN · Real-Time Price · USD

156.89

+0.44 (0.28%)

At close: Aug 17, 2026, 4:00 PM EDT

156.95

+0.06 (0.04%)

After-hours: Aug 17, 2026, 7:52 PM EDT

AstraZeneca Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	243,057	287,813	203,171	209,268	209,442	182,034
Market Cap Growth	0.60%	41.66%	-2.91%	-0.08%	15.06%	38.68%
Enterprise Value	271,110	312,406	228,175	234,801	238,391	209,520
Last Close Price	156.89	172.53	125.08	128.55	130.24	110.76

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	23.27	28.15	28.88	35.14	63.70	1625.31
PS Ratio	3.96	4.90	3.76	4.57	4.72	4.87
PB Ratio	4.83	5.91	4.97	5.34	5.65	4.63
P/FCF Ratio	22.78	24.46	20.45	23.29	24.03	37.36
P/OCF Ratio	17.74	19.75	17.13	20.23	21.35	30.53

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.42	5.32	4.22	5.13	5.38	5.60
EV/EBITDA Ratio	13.62	16.20	12.99	16.45	17.35	31.27
EV/EBIT Ratio	18.52	21.86	17.65	24.21	27.05	72.32
EV/FCF Ratio	25.41	26.55	22.96	26.14	27.35	43.01

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.64	0.61	0.75	0.76	0.84	0.85
Debt / EBITDA Ratio	1.59	1.51	1.70	2.04	2.23	4.81
Debt / FCF Ratio	3.03	2.53	3.07	3.30	3.57	6.85
Net Debt / Equity Ratio	0.54	0.49	0.61	0.61	0.67	0.69
Net Debt / EBITDA Ratio	1.38	1.24	1.42	1.67	1.81	4.02
Net Debt / FCF Ratio	2.57	2.04	2.51	2.65	2.86	5.54
Asset Turnover	0.54	0.54	0.53	0.46	0.44	0.44
Inventory Turnover	1.68	1.81	1.80	1.59	1.26	1.85
Quick Ratio	0.66	0.65	0.67	0.58	0.62	0.67
Current Ratio	0.89	0.94	0.93	0.82	0.86	1.16
Return on Equity (ROE)	21.96%	22.84%	17.59%	15.64%	8.63%	0.42%
Return on Assets (ROA)	8.02%	8.19%	7.88%	6.13%	5.46%	2.10%
Return on Invested Capital (ROIC)	16.05%	17.03%	16.27%	13.42%	13.75%	6.00%
Return on Capital Employed (ROCE)	17.40%	17.10%	17.00%	13.70%	12.60%	3.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.30%	3.55%	3.46%	2.85%	1.57%	0.06%
FCF Yield	4.39%	4.09%	4.89%	4.29%	4.16%	2.68%
Dividend Yield	2.06%	1.85%	2.48%	2.26%	2.23%	2.59%
Payout Ratio	48.35%	47.39%	65.47%	75.42%	132.72%	3442.86%
Buyback Yield / Dilution	0.03%	0.06%	-0.06%	-0.13%	-9.32%	-8.68%
Total Shareholder Return	2.09%	1.92%	2.42%	2.13%	-7.09%	-6.09%

SEC Filings: 10-K · 10-Q